CTAS

Cintas Corporation and Lemongrass Complete Major SAP Migration to Google Cloud with Minimal Downtime

Retrieved on: 
Mardi, novembre 14, 2023
ECC, Cortex, Cymbopogon, Microsoft Power Platform, Google Cloud Platform, Architecture, SAP, GCP, Risk, Database, CTAS, Cloud-native computing, SAP S/4HANA, DB2, LCP, RISE, Growth, Agility, Google Cloud, TB, Patent, Mobile phone, Video game, Cryptocurrency, Cloud, Oracle, Cintas

The engagement also included collaborating on a RISE with SAP use case for one of the Cintas Corporation’s business units with SAP S/4HANA.

Key Points: 
  • The engagement also included collaborating on a RISE with SAP use case for one of the Cintas Corporation’s business units with SAP S/4HANA.
  • To minimize their risk, Cintas requested a lift-and-shift migration and directed Google to recommend their most experienced migration solution provider to assist with the project.
  • Lemongrass executed a flawless migration of the Cintas SAP estate to Google Cloud with minimal downtime.
  • “Due to this migration, Cintas will be able to significantly accelerate our AI and analytics journey with SAP on Google Cloud Platform.

Cintas Corporation Announces Webcast for Second Quarter Fiscal Year 2024 Results

Retrieved on: 
Jeudi, décembre 7, 2023
Commercial Building & Real Estate, Construction & Property, Office Products, Other Retail, Building Systems, Fashion, Retail, Other Construction & Property, Residential Building & Real Estate, Webcast, Cintas, Corporation, Eastern Time Zone, CTAS, Cryptocurrency, Broadcasting

Cintas Corporation (Nasdaq:CTAS) today announced that it will release fiscal year 2024 second quarter results on Thursday, December 21, 2023.

Key Points: 
  • Cintas Corporation (Nasdaq:CTAS) today announced that it will release fiscal year 2024 second quarter results on Thursday, December 21, 2023.
  • The Company will conduct a conference call to address the financial results.
  • A live webcast of the call will be available to individual investors and the public beginning at 10:00 a.m., Eastern Time, on Thursday, December 21, 2023.
  • For those unable to listen to the live webcast, a replay will be available on the Company's website beginning approximately two hours after the completion of the live call and will remain available for two weeks.

Cintas Corporation earns 2024 Military Friendly® Employer Designation

Retrieved on: 
Jeudi, novembre 16, 2023
Professional Services, Defense, Other Manufacturing, DEI (Diversity, Equity and Inclusion), Chemicals, Plastics, Human Resources, Medical Supplies, Environmental, Social and Governance (ESG), Manufacturing, Health, Veterans, Military, Human resources, Workforce, Corporation, CTAS, Multimedia, Culture, Inclusion, Equity, Cintas, Veteran, Spouse, Bronze, Military personnel, Management

Cintas Corporation (Nasdaq: CTAS) announced today that it has earned two 2024 Military Friendly® designations, including the designation as a 2024 Bronze Military Friendly Employer and a Military Spouse Friendly Employer.

Key Points: 
  • Cintas Corporation (Nasdaq: CTAS) announced today that it has earned two 2024 Military Friendly® designations, including the designation as a 2024 Bronze Military Friendly Employer and a Military Spouse Friendly Employer.
  • View the full release here: https://www.businesswire.com/news/home/20231116588332/en/
    Cintas Corporation was designated a 2024 Bronze Military Friendly Employer and a Military Spouse Friendly Employer.
  • (Graphic: Business Wire)
    Cintas earned the Bronze Military Friendly Employer for the third year in a row and was also honored with the Military Friendly Spouse Employer designation for the second year in a row.
  • Institutions earning the Military Friendly® Employer designation were evaluated using both public data sources and responses from a proprietary survey.

Cintas Opens New Cleanroom Facility in Milwaukee Area

Retrieved on: 
Mercredi, novembre 15, 2023
Research, Pharmaceutical, Technology, Medical Devices, Semiconductor, Science, Nanotechnology, Biotechnology, Automotive Manufacturing, Other Technology, Aerospace, Health, Manufacturing, Corporation, History, CTAS, Multimedia, ISO, Cintas, Growth, Certification, Self storage, Renewable energy, Personal protective equipment, Cleanroom

Cintas Corporation (Nasdaq: CTAS) today held a grand opening ceremony at its newest Cleanroom facility, located outside of Milwaukee.

Key Points: 
  • Cintas Corporation (Nasdaq: CTAS) today held a grand opening ceremony at its newest Cleanroom facility, located outside of Milwaukee.
  • View the full release here: https://www.businesswire.com/news/home/20231115521502/en/
    Cintas employee-partners cutting the ribbon at the Menomonee Falls Cleanroom grand opening.
  • (Photo: Business Wire)
    The state-of-the-art facility in Menomonee Falls creates additional capacity in Cintas’ national Cleanroom footprint.
  • Dedicated Cleanroom quality managers monitor Cintas’ Cleanroom facilities as part of a comprehensive total quality management program.

Janus Henderson’s Biotech team recognized by With Intelligence’s HFM “Sector Specialist” Award

Retrieved on: 
Lundi, novembre 13, 2023
Data Analytics, Asset Management, Professional Services, Finance, Janus, Growth, Hedge fund, Janus Henderson, Research, NYSE, HFM, CTAS, Intelligence, Cryptocurrency, Biotechnology

Janus Henderson Investors (NYSE/ASX: JHG) today announced that its Biotech team was recognized by With Intelligence, winning the HFM (Hedge Fund Manager) U.S.

Key Points: 
  • Janus Henderson Investors (NYSE/ASX: JHG) today announced that its Biotech team was recognized by With Intelligence, winning the HFM (Hedge Fund Manager) U.S.
  • The Janus Henderson biotech team won in the Sector Specialist category over other sector-specific teams.
  • Janus Henderson’s biotech team utilizes deep fundamental research to identify companies trading at significant disparities from intrinsic value.
  • The award signifies much-deserved recognition of Janus Henderson’s efforts to deliver the firm’s market-leading biotech capabilities to qualified clients.

Wave Life Sciences Reports Third Quarter 2023 Financial Results and Provides Business Update

Retrieved on: 
Jeudi, novembre 9, 2023
Research, Q&A, Dystrophin, DSM-IV codes, Biomarker, Therapy, Obesity, CSF, RNA, Pizzicato, Human, HD, MD, Coronary artery disease, Liver, CNS, Exon, MBA, Liver disease, Oligonucleotide, Pharmacokinetics, CTAS, Clinical trial, Webcast, Messenger, GSK, Serum, AATD, Safety, DMD, N-Acetylgalactosamine, Patient, Small RNA, NHP, Mutation, Vaccine, Medical imaging, Cryptocurrency, Pharmaceutical industry, Takeda, Wave

ET today

Key Points: 
  • ET today
    CAMBRIDGE, Mass., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage RNA medicines company committed to delivering life-changing treatments for people battling devastating diseases, today announced financial results for the third quarter ended September 30, 2023, and provided a business update.
  • Wave expects to initiate dosing with WVE-006 in healthy volunteers in the fourth quarter of 2023 and deliver proof-of-mechanism data in individuals with AATD in 2024.
  • Wave remains on track to initiate dosing in FORWARD-53 in 2023 and enroll up to 10 boys in the trial.
  • ET to review third quarter 2023 financial results and pipeline updates.

Cintas Launches Bleeding Control Training

Retrieved on: 
Jeudi, novembre 9, 2023
Public Policy, Government, Nursing, Managed Care, Medical Supplies, General Health, Health, Law Enforcement, Emergency Services, Hospitals, Knowledge, Injury, Cintas, Workplace, CTAS, American Heart Association, PPE, Bleeding, Multimedia, CPR, Emergency bleeding control, AED, Accident, AHA, Birth control

Cintas Corporation (Nasdaq: CTAS), the largest national provider of American Heart Association (AHA) CPR and AED trainings, today launched its Bleeding Control Training Program.

Key Points: 
  • Cintas Corporation (Nasdaq: CTAS), the largest national provider of American Heart Association (AHA) CPR and AED trainings, today launched its Bleeding Control Training Program.
  • View the full release here: https://www.businesswire.com/news/home/20231004256146/en/
    Cintas launches Bleeding Control Training Program.
  • (Photo: Business Wire)
    The Cintas Bleeding Control Training course covers scene safety, PPE usage, wound identification and hands-on tourniquet application and wound packing.
  • For more information about the Bleeding Control Training Program or to inquire about scheduling a training session, visit www.cintas.com/firstaidsafety .

Insider Announces 110+ New Customers, Unveils World's Most Advanced Generative AI Solution for CX, Sirius AI™, and Launches Industry-Leading Capabilities in Q3'23

Retrieved on: 
Jeudi, novembre 9, 2023
E-commerce, LLM, Customer data platform, Meta, Service, Digital, Risk, AWS, GDPR, Marketing, Extract, transform, load, CX, Human, Lightning, PwC, Personal software process, Workforce, News, Acquisition, Personalization, QNB, Mobile marketing, Machine learning, Magic Quadrant, Data activism, Synthetic media, IDC, Nike, WhatsApp, CDP, Travel, CCPA, Communication, SMS, Insider, API, Sirius, City, CTAS, Amplitude, Services and supports for people with disabilities, Consultant, Algorithm, Sales, Tourism, Online shopping, Mobile phone, New Balance, Unilever, Twilio, ShopRite, Pixmania, Adjustment, LinkedIn, Gartner, G2

Insider continues to pave the way in revolutionizing CX and making marketing teams more efficient and productive.

Key Points: 
  • Insider continues to pave the way in revolutionizing CX and making marketing teams more efficient and productive.
  • In Gartner's Magic Quadrant for Personalization Engines 2023 , Insider became the fastest-moving player, making the biggest leaps for three consecutive years.
  • Insider also achieved the highest scores in all three personalization use cases – Marketing (3.99/5.0), Digital Commerce (4.11/5.0), and Services and Support (3.94/5.0).
  • Earlier this quarter, Insider unveiled Sirius AI™ , the world's leading Generative AI solution designed to transform customer experience creation at every level.

Evolv AI Uses Active Learning Capabilities to Fuel Generative AI Product Features - Now Open to the Public

Retrieved on: 
Lundi, novembre 6, 2023
UI, Evolving digital ecological network, AI, CSS, CTAS, HTML, Creativity, SAN, Sales, Online shopping

SAN FRANCISCO, Nov. 6, 2023 /PRNewswire/ -- Evolv AI, the creator of the world's leading intelligent digital experience optimization and personalization platform, unveiled three groundbreaking generative AI features to its core platform throughout the summer of 2023. These innovations are driven by Evolv AI's commitment to using active learning, which aims to automate the design thinking process and close the loop on AI-led experimentation, allowing businesses to take control of the entire experimentation process — streamlining the journey from idea inception to delivering intelligent, personalized digital experiences.

Key Points: 
  • Evolv AI unveils transformative generative AI features, accelerating digital experimentation and personalization for businesses.
  • SAN FRANCISCO, Nov. 6, 2023 /PRNewswire/ -- Evolv AI, the creator of the world's leading intelligent digital experience optimization and personalization platform, unveiled three groundbreaking generative AI features to its core platform throughout the summer of 2023.
  • AI image design enables teams to create, crop, and resize unique images for digital experiences, all within Evolv AI's UI.
  • All of the generative AI features launched this summer are now available to Evolv AI customers who value experimentation and testing as integral to building exceptional digital experiences and seek to capitalize on the massive opportunity AI provides.

EQS-News: Galimedix Appoints Dr. Luciana Summo as Vice President, R&D Operations

Retrieved on: 
Jeudi, octobre 26, 2023
FDA, Noxxon Pharma, IND, Food, Ophthalmology, Berlin, Appointment for the Spies, CMC, US Foods, News, Doctor of Philosophy, ChromeOS, R, D, Cardiology, Myenteric plexus, Rest, CTAS, Therapy, Investigational New Drug, Medical device, Pharmaceutical industry, MD

Galimedix Appoints Dr. Luciana Summo as Vice President, R&D Operations (news with additional features)

Key Points: 
  • Galimedix Appoints Dr. Luciana Summo as Vice President, R&D Operations (news with additional features)
    The issuer is solely responsible for the content of this announcement.
  • In this newly created position, she will oversee all activities related to R&D operations, with an emphasis on clinical development and operations.
  • “We are delighted to welcome Luciana to Galimedix,” said Alexander Gebauer, MD, PhD, Co-founder and Executive Chairman.
  • Luciana Summo, PhD, Vice President, R&D Operations, added: “I am truly excited to be joining Galimedix at this important point in the Company’s growth.